Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain

Acta Biologica Hungarica

Volumn 54, Issue 2, 2003, Pages 183-189

  Rakonczay, Z ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Molecular forms

Indexed keywords

ACETYLCHOLINESTERASE; BENZAZEPINE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DRUG DERIVATIVE; EDROPHONIUM; METRIFONATE; PHYSOSTIGMINE; PHYSOSTIGMINE HEPTYL; RIVASTIGMINE; TACRINE; ZANEPEZIL;

ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN CORTEX; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; HUMAN; IN VITRO STUDY; METABOLISM;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; BENZAZEPINES; BRAIN; BUTYRYLCHOLINESTERASE; CARBAMATES; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; EDROPHONIUM; HUMANS; PHENYLCARBAMATES; PHYSOSTIGMINE; TACRINE; TRICHLORFON;

EID: 0042286681     PISSN: 02365383     EISSN: None     Source Type: Journal    
DOI: 10.1556/ABiol.54.2003.2.7     Document Type: Article

References (23)

1. Atack, J. R., Perry, E. K., Bonham, J. R., Perry, R. H., Tomlinson, B. E., Blessed, G., Fairbairn, A. (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40, 199-204.
2. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Ellman, G. L., Courtney, D. K., Andres, V., Featherstone, R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
4. 4 isolated from Alzheimer's disease and control brains. In: Shafferman, A., Velan, B. (eds) Multidisciplinary Approaches to Cholinesterase Functions. Plenum Press, New York, pp. 243-249.
5. Fishman, E. B., Siek, G. C., MacCallum, R. D., Bird, E. D., Volicer, L., Malquis, J. K. (1986) Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of Alzheimer type. Ann. Neurol. 19, 246-252.
6. Giacobini, E. (1997) From molecular structure to Alzheimer therapy. Jpn. J. Pharmacol. 74, 225-241.
7. Giacobini, E. (2001) Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease? CNS Drugs 15, 85-91.
8. Johnson C. D., Russel, R. L. (1975) A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64, 229-238.
9. Kasa, P., Rakonczay, Z., Gulya, K. (1997) The cholinergic system in Alzheimer's disease. Progr. Neurobiol. 52, 511-535.
10. Nakamura, S., Kawashima, S., Nakano, S., Tsuji, T., Araki, W. (1990) Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization. J. Neural Transm. Suppl. 30, 13-23.
11. Ogane, N., Giacobini, E., Struble, R. (1992) Preferential inhibition of acetylcholinesterase molecular forms in rat brain. Neurochem. Res. 17, 489-495.
12. Ogane, N., Giacobini, E., Struble, R. (1992) Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain. Brain Res. 589, 307-312.
13. Pang, Y. P., Quiram, P., Jelacic, T., Hong, F., Brimijoin, S. (1996) Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J. Biol. Chem. 271, 23646-23649.
14. Rakonczay, Z. (1988) Cholinesterase and its molecular forms in pathological states. Progr. Neurobiol. 31, 311-330.
15. Rakonczay, Z., Brimijoin, S. (1988) Monoclonal antibodies to human brain acetylcholinesterase: Properties and applications. Cell. Molec. Neurobiol. 8, 85-93.
16. Rakonczay, Z., Mallol, I., Schenk, H., Vincendon, G., Zanetta, J.-P. (1981) Purification and properties of the membrane-bound acetylcholinesterase from adult rat brain. Biochim. Biophys. Acta 657, 243-256.
17. Rakonczay, Z., Kovács, I. (1998) Cholinesterases in Alzheimer's disease and cholinesterase inhibitors in Alzheimer's therapy. Acta. Biol. Hung. 49, 55-70.
18. Rakonczay, Z., Vincendon, G., Zanetta, J.-P. (1981) Heterogeneity of rat brain acetylcholinesterase: A study by gel filtration and gradient centrifugation. J. Neurochem. 37, 662-669.
19. Siek, G. C., Katz, L. S., Fishman, E. B., Korosi, T. S., Marquis, J. K. (1990) Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer's disease brain. Biol. Psychiatry 27, 573-580.
20. Skau, K. A. (1981) Ethopropazine inhibition of AChE molecular forms. Pharmacologist 24, 224.
21. Vigny, M., Bon, S., Massoulie, J., Leterrier, F. (1978) Active-site catalytic efficiency of acetylcholinesterase molecular forms in Electrophorus, Torpedo, rat and chicken. Eur. J. Biochem. 85, 317-323.
22. Younkin, S. G., Goodridge, B., Katz, J., Lockett, G., Nafziger, D., Usiak, M. F., Younkin, L. H. (1986) Molecular forms of acetylcholinesterase in Alzheimer's disease. Fed. Proc. 45, 2982-2988.
23. Zhao, Q., Tang, X. C. (2002) Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Eur. J. Pharmacol. 455, 101-107.